Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vucic

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Data in Brief|March 10, 2017
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosisN Fewings, P N Gatt, F C McKay, et al.
Journal of Autoimmunity|January 9, 2017
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosisN L Fewings, P N Gatt, F C McKay, et al.
Journal of the Neurological Sciences|March 3, 2021
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapyM Garcia-Montojo, S Fathi, G Norato, et al.
Journal of Dental Research|November 28, 2022
Novel Genetic Determinants of Dental Maturation in ChildrenO Grgic, V Prijatelj, A Dudakovic, et al.
Journal of Dental Research|January 25, 2018
Rare and Common Variants Conferring Risk of Tooth AgenesisL Jonsson, T E Magnusson, A Thordarson, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Data in Brief|March 10, 2017
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosisN Fewings, P N Gatt, F C McKay, et al.
Journal of Autoimmunity|January 9, 2017
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosisN L Fewings, P N Gatt, F C McKay, et al.
Journal of the Neurological Sciences|March 3, 2021
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapyM Garcia-Montojo, S Fathi, G Norato, et al.
Journal of Dental Research|November 28, 2022
Novel Genetic Determinants of Dental Maturation in ChildrenO Grgic, V Prijatelj, A Dudakovic, et al.
Journal of Dental Research|January 25, 2018
Rare and Common Variants Conferring Risk of Tooth AgenesisL Jonsson, T E Magnusson, A Thordarson, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 4